Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Shares  >  Nasdaq  >  Vertex Pharmaceuticals Incorporated    VRTX   US92532F1003

Delayed Quote. Delayed Nasdaq - 07/02 04:00:00 pm
131.26 USD   +4.02%
07/03 VERTEX PHARMACE : drug gets FDA approval
07/02 VERTEX PHARMACE : ADDING MULTIMEDIA FDA Approves ORKAMBI™ (lum..
07/02DJVERTEX PHARMACE : $259,000 Cystic Fibrosis Drug Approved
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
06/26/2015 06/29/2015 06/30/2015 07/01/2015 07/02/2015 Date
126.87(c) 122.03(c) 123.48(c) 126.19(c) 131.26(c) Last
4 661 797 1 288 950 1 501 378 1 451 141 3 652 747 Volume
-1.15% -3.81% +1.19% +2.19% +4.02% Change
More quotes
Financials ($)
Sales 2015 1 013 M
EBIT 2015 -357 M
Net income 2015 -487 M
Finance 2015 456 M
Yield 2015 -
Sales 2016 2 886 M
EBIT 2016 1 192 M
Net income 2016 981 M
Finance 2016 1 145 M
Yield 2016 -
PER 2015 -
PER 2016 36,48
EV / Sales 2015 31,1x
EV / Sales 2016 10,7x
Capitalization 31 995 M
More Financials
Company
Vertex Pharmaceuticals, Inc. engages in the business of discovering, developing, manufacturing, and commercializing small molecule drugs for patients with serious diseases in specialty markets.It focuses on development and commercializing therapies for the treatment of cystic fibrosis; infectious... 
Sector
Pharmaceuticals
Calendar
07/27Earnings Release
More about the company
Surperformance© ratings of Vertex Pharmaceuticals Inc
Trading Rating : Investor Rating :
More Ratings
Latest news on VERTEX PHARMACEUTICALS INC
07/03 VERTEX PHARMACEUTICALS : drug gets FDA approval
07/02 VERTEX PHARMACEUTICALS : ADDING MULTIMEDIA FDA Approves ORKAMBI™ (lumacaft..
07/02DJVERTEX PHARMACEUTICALS : $259,000 Cystic Fibrosis Drug Approved
07/02 VERTEX PHARMACEUTICALS : FDA approves new combination pill for cystic fibrosis f..
07/02 VERTEX PHARMACEUTICALS : FDA clears drug for leading form of cystic fibrosis
07/01 VERTEX PHARMACEUTICALS : New Findings on Hepatitis C Virus from Vertex Pharmaceu..
06/26 VERTEX PHARMACEUTICALS : Assigned Patent
06/26 VERTEX PHARMACEUTICALS : Sangeeta Names Dr. N. Bhatia to Board
More news
Sector news : Biopharmaceuticals
01:00a OPKO HEALTH : and Bio-Reference Laboratories Announce Early Termination of the W..
07/03 Exclusive - Hospira wins French biosimilar drug tender at 45 percent discount
07/03 MALLINCKRODT : takes on FDA in fight over ADHD generic
More sector news : Biopharmaceuticals
News from SeekingAlpha
07/02 SEEKING ALPHA'S BIOTECH WEEKLY : Celgene-Juno, Gilead's HIV NDA, Happy 4th!
07/02 FDA clears Vertex's Orkambi; shares up 4%
06/26 VERTEX PHARMA : Well Positioned To Set New Highs
06/25 After Hours Gainers / Losers
06/19 Is Biotech Finally In A Bubble?


Comments 
Advertisement
Chart VERTEX PHARMACEUTICALS INC
Duration : Period :
Vertex Pharmaceuticals Inc Technical Analysis Chart | VRTX | US92532F1003 | 4-Traders
Full-screen chart
Technical analysis trends
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions